DSE:PRIMELIFE Statistics

Total Valuation

DSE:PRIMELIFE has a market cap or net worth of BDT 998.01 million. The enterprise value is 705.45 million.

Market Cap	998.01M
Enterprise Value	705.45M

Important Dates

The next estimated earnings date is Wednesday, June 24, 2026.

Earnings Date	Jun 24, 2026
Ex-Dividend Date	n/a

Share Statistics

DSE:PRIMELIFE has 30.52 million shares outstanding.

Current Share Class	30.52M
Shares Outstanding	30.52M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.24
PB Ratio	2.84
P/TBV Ratio	9.27
P/FCF Ratio	39.39
P/OCF Ratio	30.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.06
EV / Sales	0.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	27.85

Financial Position

The company has a current ratio of 3.54

Current Ratio	3.54
Quick Ratio	3.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-46.01

Financial Efficiency

Return on equity (ROE) is -96.45% and return on invested capital (ROIC) is -56.89%.

Return on Equity (ROE)	-96.45%
Return on Assets (ROA)	-2.54%
Return on Invested Capital (ROIC)	-56.89%
Return on Capital Employed (ROCE)	-4.42%
Revenue Per Employee	4.01M
Profits Per Employee	-334,264
Employee Count	1,025
Asset Turnover	0.50
Inventory Turnover	n/a

Taxes

In the past 12 months, DSE:PRIMELIFE has paid 2.55 million in taxes.

Income Tax	2.55M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.25% in the last 52 weeks. The beta is 0.51, so DSE:PRIMELIFE's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-3.25%
50-Day Moving Average	37.04
200-Day Moving Average	37.18
Relative Strength Index (RSI)	43.09
Average Volume (20 Days)	42,322

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:PRIMELIFE had revenue of BDT 4.11 billion and -342.62 million in losses. Loss per share was -11.23.

Revenue	4.11B
Gross Profit	415.56M
Operating Income	-332.88M
Pretax Income	-350.21M
Net Income	-342.62M
EBITDA	-321.09M
EBIT	-332.88M
Loss Per Share	-11.23

Full Income Statement

Balance Sheet

The company has 536.29 million in cash and n/a in debt, giving a net cash position of 536.29 million or 17.57 per share.

Cash & Cash Equivalents	536.29M
Total Debt	n/a
Net Cash	536.29M
Net Cash Per Share	17.57
Equity (Book Value)	351.36M
Book Value Per Share	3.53
Working Capital	1.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 32.32 million and capital expenditures -6.98 million, giving a free cash flow of 25.33 million.

Operating Cash Flow	32.32M
Capital Expenditures	-6.98M
Free Cash Flow	25.33M
FCF Per Share	0.83

Full Cash Flow Statement

Margins

Gross margin is 10.12%, with operating and profit margins of -8.11% and -8.34%.

Gross Margin	10.12%
Operating Margin	-8.11%
Pretax Margin	-8.53%
Profit Margin	-8.34%
EBITDA Margin	-7.82%
EBIT Margin	-8.11%
FCF Margin	0.62%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.31%.

Dividend Per Share	0.10
Dividend Yield	0.31%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	0.31%
Earnings Yield	-34.33%
FCF Yield	2.54%

Dividend Details

Stock Splits

The last stock split was on August 9, 2016. It was a forward split with a ratio of 1.05.

Last Split Date	Aug 9, 2016
Split Type	Forward
Split Ratio	1.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	3